Published

From trials to clinics: investigators' perspectives on translating psychedelic research into clinical care.

An abstract is available from the original source but is not redistributed by this tracker. Read the source record.

Open source BibTeX RIS

Bibliographic context

Journal: Translational behavioral medicine
Date: 2026-01-07
Source: PubMed
DOI: 10.1093/tbm/ibag027
PubMed: 42152689

Authors

Mitchell J Neitzke-Spruill L Mathai DS Robinson JO Kavan Z Averil LA McGuire AL

Watch author

Derived topics and classifications

psilocybin Depression PTSD Addiction Clinical Trial Treatment-Resistant Depression Clinical Trial

Citation graph

0 referenced DOIs found in stored source metadata. 2 indexed papers cite this DOI.

Open citation network

Indexed papers citing this DOI

Psilocybin and Mental Health Outcomes: Scoping Review with ☸️SAIMSARA2026-06-15 From trials to clinics: investigators' perspectives on translating psychedelic research into clinical care.2026-01-07

Related papers

Editorial: Psychedelic-assisted psychotherapies: from clinical trials to credibility.Frontiers in neuroscience · 2026-01-01 Should addiction researchers be interested in psychedelic science?Drug and Alcohol Review · 2017-04-10 Exploring the integration of psychedelic-assisted therapy and digital mental health interventions in trauma recovery for underserved adults with high-functioning autismMagna Scientia Advanced Research and Reviews · 2025-06-28 Alternative therapy for neurological and psychiatric disorders using psilocybinSão Paulo Medical Journal · 2025-01-01 Psychedelic drugs-a new era in psychiatry?.Dialogues in clinical neuroscience · 2019-01-01 Psilocybin-Assisted Group Integration Psychotherapy for Treatment-Resistant DepressionClinicalTrials.gov · 2026-07-30 Psilocybe Cubensis Mushrooms With or Without Fluoxetine for Refractory DepressionClinicalTrials.gov · 2026-03-27 Safety and Psychological Effects of Psilocybin and D-Serine Formulation in Healthy VolunteersClinicalTrials.gov · 2026-02-05